Trial Profile
Exploratory randomized trial of evaluation for Tiotropium in lung cancer surgery
Status:
Active, no longer recruiting
Phase of Trial:
Phase II
Latest Information Update: 17 Mar 2022
Price :
$35
*
At a glance
- Drugs Tiotropium bromide (Primary) ; Beta 2 adrenergic receptor agonists; Cholinergic receptor antagonists
- Indications Asthma; Chronic obstructive pulmonary disease; Postoperative complications
- Focus Pharmacodynamics
- 11 May 2020 Planned End Date changed from 31 Oct 2019 to 29 Feb 2020.
- 11 Nov 2019 Planned End Date changed from 31 Mar 2018 to 31 Oct 2019.
- 10 May 2018 Status changed from suspended to active, no longer recruiting.